Altered dimer interface decreases stability in an amyloidogenic protein

被引:96
作者
Baden, Elizabeth M. [1 ]
Owen, Barbara A. L. [2 ,3 ]
Peterson, Francis C. [4 ]
Volkman, Brian F. [4 ]
Ramirez-Alvarado, Marina [1 ]
Thompson, James R.
机构
[1] Mayo Clin, Dept Biochem & Mol Biol, Coll Med, Rochester, MN 55905 USA
[2] Mayo Clin, Dept Mol Pharmacol & Expt Therapeut, Coll Med, Rochester, MN 55905 USA
[3] Mayo Clin, Dept Physiol & Biomed Engn, Coll Med, Rochester, MN 55905 USA
[4] Med Coll Wisconsin, Dept Biochem, Milwaukee, WI 53226 USA
关键词
D O I
10.1074/jbc.M705347200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Amyloidoses are devastating and currently incurable diseases in which the process of amyloid formation causes fatal cellular and organ damage. The molecular mechanisms underlying amyloidoses are not well known. In this study, we address the structural basis of immunoglobulin light chain amyloidosis, which results from deposition of light chains produced by clonal plasma cells. We compare light chain amyloidosis protein AL-09 to its wild-type counterpart, the kappa I O18/O8 light chain germline. Crystallographic studies indicate that both proteins form dimers. However, AL-09 has an altered dimer interface that is rotated 90 from the kappa I O18/O8 dimer interface. The three non-conservative mutations in AL-09 are located within the dimer interface, consistent with their role in the decreased stability of this amyloidogenic protein. Moreover, AL-09 forms amyloid fibrils more quickly than kappa I O18/O8 in vitro. These results support the notion that the increased stability of the monomer and delayed fibril formation, together with a properly formed dimer, may be protective against amyloidogenesis. This could open a new direction into rational drug design for amyloidogenic proteins.
引用
收藏
页码:15853 / 15860
页数:8
相关论文
共 51 条
[11]   SUBSPECIALTY CLINICS - HEMATOLOGY - PRIMARY SYSTEMIC AMYLOIDOSIS - A DIAGNOSTIC PRIMER [J].
GERTZ, MA ;
KYLE, RA .
MAYO CLINIC PROCEEDINGS, 1989, 64 (12) :1505-1519
[12]   Sequence-dependent denaturation energetics:: A major determinant in amyloid disease diversity [J].
Hammarström, P ;
Jiang, X ;
Hurshman, AR ;
Powers, ET ;
Kelly, JW .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2002, 99 :16427-16432
[13]   COMPARISON OF CRYSTAL-STRUCTURES OF 2 HOMOLOGOUS PROTEINS - STRUCTURAL ORIGIN OF ALTERED DOMAIN INTERACTIONS IMMUNOGLOBULIN LIGHT-CHAIN DIMERS [J].
HUANG, DB ;
CHANG, CH ;
AINSWORTH, C ;
BRUNGER, AT ;
EULITZ, M ;
SOLOMON, A ;
STEVENS, FJ ;
SCHIFFER, M .
BIOCHEMISTRY, 1994, 33 (49) :14848-14857
[14]   Variable domain structure of κIV human light chain Len:: High homology to the murine light chain McPC603 [J].
Huang, DB ;
Chang, CH ;
Ainsworth, C ;
Johnson, G ;
Solomon, A ;
Stevens, FJ ;
Schiffer, M .
MOLECULAR IMMUNOLOGY, 1997, 34 (18) :1291-1301
[15]   Thermodynamic modulation of light chain amyloid fibril formation [J].
Kim, YS ;
Wall, JS ;
Meyer, J ;
Murphy, C ;
Randolph, TW ;
Manning, MC ;
Solomon, A ;
Carpenter, JF .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (03) :1570-1574
[16]   Amyloid diseases: Abnormal protein aggregation in neurodegeneration [J].
Koo, EH ;
Lansbury, PT ;
Kelly, JW .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (18) :9989-9990
[17]  
Krissinel E, 2005, LECT NOTES COMPUT SC, V3695, P163
[18]  
KYLE RA, 1995, SEMIN HEMATOL, V32, P45
[19]   PROCHECK - A PROGRAM TO CHECK THE STEREOCHEMICAL QUALITY OF PROTEIN STRUCTURES [J].
LASKOWSKI, RA ;
MACARTHUR, MW ;
MOSS, DS ;
THORNTON, JM .
JOURNAL OF APPLIED CRYSTALLOGRAPHY, 1993, 26 :283-291
[20]   The effects of sodium sulfate, glycosaminoglycans, and Congo red on the structure, stability, and amyloid formation of an immunoglobulin light-chain protein [J].
McLaughlin, Richard W. ;
De Stigter, Janelle K. ;
Sikkink, Laura A. ;
Baden, Elizabeth M. ;
Ramirez-Alvarado, Marina .
PROTEIN SCIENCE, 2006, 15 (07) :1710-1722